Lantern Pharma Inc. (LTRN) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Lantern Pharma Inc. (LTRN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Lantern Pharma Inc., the average estimate for 2030 earnings per share is −$2.38; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Lantern Pharma Inc. (LTRN) forecast — frequently asked questions
What are analysts forecasting for Lantern Pharma Inc.'s earnings?
The average analyst estimate for Lantern Pharma Inc. (LTRN) earnings per share in 2030 is -2.38, with individual estimates between -2.38 and -2.38.
How much revenue is Lantern Pharma Inc. expected to make?
Analysts forecast Lantern Pharma Inc. (LTRN) revenue of $0 in 2030, based on 1 published estimates.
How many analysts cover LTRN?
1 analyst contribute estimates for Lantern Pharma Inc. (LTRN). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.